Our research at the Laufer Center (LC) benefits from federal funding from the National Institutes of Health (NIH) and National Science Foundation (NSF) and the Research Corporation for Science Advancement for our Covid-19 research. We appreciate extensive supercomputing from NSF Frontera, from the HPC COVID-19 Consortium, from Zeblok Computational and the Center of Excellence Wireless and Information Technology (CEWIT) at Stony Brook University. We enjoy current collaborations with Andrej Sali and his colleagues of the UCSF QBI Covid Research Group, and past engagements with Merck, Zymeworks, Regeneron and Janssen Pharmaceuticals. We are particularly grateful for exceptional support from Stony Brook University and Nancy Rohring (LC Administrative Director), Diane Vigliotta (LC Grants Administrator), Feng Zhang (LC Senior Programmer Analyst) in the Laufer Center, and Sarina Bromberg (Graphics & Editing). In addition, for the stunning homepage image of the COVID-19 spike protein binding to the ACE-2 receptor, depicting her work in Carlos Simmerling’s group, we thank Lucy Fallon.
COVID Virus Drug Discovery at the Laufer Center 